FDA Approves Bristol-Myers, AstraZeneca Diabetes Drug
The U.S. Food and Drug Administration on Wednesday approved a Bristol-Myers Squibb Co. and AstraZeneca Pharmaceuticals LP drug designed to treat Type 2 diabetes, about one year after rejecting the same...To view the full article, register now.
Already a subscriber? Click here to view full article